Pricing Log in Create free account

BioMarin Pharmaceutical Inc. (BMRN) vs Krystal Biotech, Inc. (KRYS)

BioMarin Pharmaceutical Inc. and Krystal Biotech, Inc. are both Biotechnology companies. BioMarin Pharmaceutical Inc. is the larger, with a market value of $10.9B against $9.8B — 1.1× the size. Krystal Biotech, Inc. trades at the lower P/E: 38.3× against 144×. Krystal Biotech, Inc. grew revenue faster over the last twelve months: 22.6% against 11.2%. Krystal Biotech, Inc. has the higher net margin (54.8% vs 2.14%) and the higher return on invested capital (24.1% vs 0.97%). Across the 21 metrics below, Krystal Biotech, Inc. leads on 16 and BioMarin Pharmaceutical Inc. on 5.

Valuation

Metric BMRN KRYS Biotechnology median
P/E 143.89 38.28 8.50
P/S 3.10 21.22 9.71
P/B 1.67 6.88 2.13
Price to free cash flow 14.59 36.26 20.82
EV/EBITDA 46.69 41.59 0.64
EV/Sales 4.08 19.30 9.21
Earnings yield 0.69% 2.61% (33.15%)
Free cash flow yield 6.85% 2.76% (25.50%)

Profitability

Metric BMRN KRYS Biotechnology median
Gross margin 76.12% 94.64% 65.16%
Operating margin 4.38% 44.89% 0.00%
Net margin 2.14% 54.82% 0.00%
Free cash flow margin 21.28% 58.52% 0.00%
Return on equity 1.18% 20.12% (56.36%)
Return on assets 0.76% 18.30% (48.04%)
Return on invested capital 0.97% 24.07% 0.00%

Growth

Metric BMRN KRYS Biotechnology median
Revenue growth (TTM) 11.20% 22.63% 6.02%
EPS growth (last fiscal year) (18.55%) 128.00% 30.26%
Revenue growth, 5-year CAGR 11.60% — 9.41%
Net income growth, 5-year CAGR (16.39%) 0.00% 0.00%

Health

Metric BMRN KRYS Biotechnology median
Debt to equity 0.66 0.00 0.00
Current ratio 2.39 8.32 4.72
Net debt to EBITDA (1.99) (4.93) 0.96

Dividend

Metric BMRN KRYS Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BMRN KRYS Biotechnology median
Market cap 10.85b 9.77b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack